444
Participants
Start Date
June 28, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Azithromycin
Prophylactic azithromycin treatment 250 mg three times weekly vs placebo
ICS
All patients will receive LABA/LAMA medication. The ICS medication will be switched on/off according to the most recent blood eosinophil count (at inclusion + every 3 months) vs continued LABA/LAMA/ICS treatment
RECRUITING
Aarhus University Hospital, Aarhus
RECRUITING
Hvidovre Hospital, Copenhagen
RECRUITING
Sydvestjysk Sygehus Esbjerg, Esbjerg
RECRUITING
Gentofte Hospital, Hellerup
RECRUITING
Nordsjællands Hospital, Hillerød
RECRUITING
Næstved-Slagelse-Ringsted Sygehus, Næstved
RECRUITING
Odense University Hospital, Odense
RECRUITING
Roskilde Sygehus, Roskilde
RECRUITING
Silkeborg Sygehus, Silkeborg
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
OTHER